{"id":"https://openalex.org/W2007444598","doi":"https://doi.org/10.1097/00005053-198506000-00008","title":"Prevalence of Movement Disorder in a Methadone-Maintained Population","display_name":"Prevalence of Movement Disorder in a Methadone-Maintained Population","publication_year":1985,"publication_date":"1985-06-01","ids":{"openalex":"https://openalex.org/W2007444598","doi":"https://doi.org/10.1097/00005053-198506000-00008","mag":"2007444598","pmid":"https://pubmed.ncbi.nlm.nih.gov/2860203"},"language":"en","primary_location":{"id":"doi:10.1097/00005053-198506000-00008","doi":"https://doi.org/10.1097/00005053-198506000-00008","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00005053-198506000-00008","pdf_url":null,"source":{"id":"https://openalex.org/S13566964","display_name":"The Journal of Nervous and Mental Disease","issn_l":"0022-3018","issn":["0022-3018","1539-736X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Nervous and Mental Disease","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079353684","display_name":"Joseph Gaspari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"JOSEPH GASPARI","raw_affiliation_strings":["Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut. Send reprint requests to Dr. Gaspari, Timberlawn Psychiatric Hospital, 4600 Samuel Boulevard, Dallas, Texas 75223"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut. Send reprint requests to Dr. Gaspari, Timberlawn Psychiatric Hospital, 4600 Samuel Boulevard, Dallas, Texas 75223","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071772360","display_name":"Robert M. Swift","orcid":"https://orcid.org/0009-0007-2335-031X","observed_orcids":["https://orcid.org/0009-0007-2335-031X"]},"institutions":[{"id":"https://openalex.org/I27804330","display_name":"Brown University","ror":"https://ror.org/05gq02987","country_code":"US","type":"education","lineage":["https://openalex.org/I27804330"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"ROBERT SWIFT","raw_affiliation_strings":["Department of Psychiatry and Human Behavior, Brown University School of Medicine, Providence, Rhode Island"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry and Human Behavior, Brown University School of Medicine, Providence, Rhode Island","institution_ids":["https://openalex.org/I27804330"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044152670","display_name":"Herbert D. Kleber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"HERBERT KLEBER","raw_affiliation_strings":["Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut. Send reprint requests to Dr. Gaspari, Timberlawn Psychiatric Hospital, 4600 Samuel Boulevard, Dallas, Texas 75223"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut. Send reprint requests to Dr. Gaspari, Timberlawn Psychiatric Hospital, 4600 Samuel Boulevard, Dallas, Texas 75223","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085449442","display_name":"Charles E. Riordan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"CHARLES RIORDAN","raw_affiliation_strings":["Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut. Send reprint requests to Dr. Gaspari, Timberlawn Psychiatric Hospital, 4600 Samuel Boulevard, Dallas, Texas 75223"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut. Send reprint requests to Dr. Gaspari, Timberlawn Psychiatric Hospital, 4600 Samuel Boulevard, Dallas, Texas 75223","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089665231","display_name":"Susan L. Santangelo","orcid":"https://orcid.org/0000-0001-5576-4495","observed_orcids":["https://orcid.org/0000-0001-5576-4495"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"SUSAN SANTANGELO","raw_affiliation_strings":["Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut. Send reprint requests to Dr. Gaspari, Timberlawn Psychiatric Hospital, 4600 Samuel Boulevard, Dallas, Texas 75223"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut. Send reprint requests to Dr. Gaspari, Timberlawn Psychiatric Hospital, 4600 Samuel Boulevard, Dallas, Texas 75223","institution_ids":["https://openalex.org/I32971472"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.11429841,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"173","issue":"6","first_page":"373","last_page":"376"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.7734000086784363,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.7734000086784363,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.053199999034404755,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.03139999881386757,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/methadone-maintenance-treatment","display_name":"methadone maintenance treatment","score":0.8370000123977661},{"id":"https://openalex.org/keywords/tardive-dyskinesia","display_name":"tardive dyskinesia","score":0.8980000019073486},{"id":"https://openalex.org/keywords/movement-disorders","display_name":"movement disorders","score":0.8830000162124634},{"id":"https://openalex.org/keywords/abnormal-involuntary-movements","display_name":"abnormal involuntary movements","score":0.9100000262260437},{"id":"https://openalex.org/keywords/abnormal-involuntary-movement-scale","display_name":"Abnormal Involuntary Movement Scale","score":0.9229999780654907},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.9160000085830688},{"id":"https://openalex.org/keywords/dopamine-receptor-antagonists","display_name":"dopamine antagonists","score":0.9409999847412109},{"id":"https://openalex.org/keywords/opioid-therapy","display_name":"opioid therapy","score":0.5669999718666077},{"id":"https://openalex.org/keywords/amphetamine-challenge","display_name":"amphetamine challenge","score":0.7450000047683716},{"id":"https://openalex.org/keywords/prevalence","display_name":"prevalence","score":0.3720000088214874}],"concepts":[{"id":"https://openalex.org/C2779158372","wikidata":"https://www.wikidata.org/wiki/Q1546328","display_name":"Tardive dyskinesia","level":3,"score":0.8580303192138672},{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.775723934173584},{"id":"https://openalex.org/C2780405171","wikidata":"https://www.wikidata.org/wiki/Q629444","display_name":"Dyskinesia","level":4,"score":0.6514384746551514},{"id":"https://openalex.org/C2778261627","wikidata":"https://www.wikidata.org/wiki/Q2608695","display_name":"Movement disorders","level":3,"score":0.6330312490463257},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.577178418636322},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5088801383972168},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.45956093072891235},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.4325691759586334},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.39910998940467834},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.34883469343185425},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21184882521629333},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.14911317825317383},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008691","descriptor_name":"Methadone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D008691","descriptor_name":"Methadone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009293","descriptor_name":"Opioid-Related Disorders","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00005053-198506000-00008","doi":"https://doi.org/10.1097/00005053-198506000-00008","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00005053-198506000-00008","pdf_url":null,"source":{"id":"https://openalex.org/S13566964","display_name":"The Journal of Nervous and Mental Disease","issn_l":"0022-3018","issn":["0022-3018","1539-736X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Nervous and Mental Disease","raw_type":"journal-article"},{"id":"pmid:2860203","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2860203","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of nervous and mental disease","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2010741056","https://openalex.org/W1965733012","https://openalex.org/W2087457861","https://openalex.org/W172732907","https://openalex.org/W2079501179","https://openalex.org/W2152509751","https://openalex.org/W4401061462","https://openalex.org/W2138627571","https://openalex.org/W2048779266","https://openalex.org/W4296954439"],"abstract_inverted_index":{"Opioids":[0],"and":[1,12],"neuroleptics":[2],"have":[3],"similar":[4],"effects":[5],"in":[6],"a":[7,26],"variety":[8],"of":[9,25],"behavioral,":[10],"biochemical,":[11],"clinical":[13],"situations.":[14],"Prolonged":[15],"treatment":[16,67],"with":[17,22,33,45,72,78],"dopamine":[18],"antagonists":[19],"is":[20],"associated":[21,71],"the":[23,61],"development":[24],"movement":[27],"disorder,":[28],"tardive":[29],"dyskinesia.":[30],"Animals":[31],"treated":[32],"methadone":[34,53],"for":[35,57],"prolonged":[36],"periods":[37],"may":[38],"also":[39,86],"develop":[40],"abnormal":[41,58,74,79],"movements":[42,59,80],"when":[43],"challenged":[44],"amphetamines.":[46],"In":[47],"this":[48],"study,":[49],"243":[50],"patients":[51,77],"on":[52],"maintenance":[54],"were":[55,81],"examined":[56],"using":[60],"Abnormal":[62],"Involuntary":[63],"Movement":[64],"Scale.":[65],"Methadone":[66],"alone":[68],"was":[69,85],"not":[70],"increased":[73],"movements.":[75],"Three":[76],"found,":[82],"but":[83],"each":[84],"receiving":[87],"neuroleptics.":[88]},"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}